Basic mechanisms of humoral rejection

Pediatric Transplantation

Volumn 9, Issue 1, 2005, Pages 9-16

  Cascalho, Marilia ^a   Platt, Jeffrey L ^a,b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

ABO blood groups; Allograft; Antibodies; B cells; Graft rejection; HLA

Indexed keywords

HLA ANTIGEN;

B LYMPHOCYTE; BLOOD GROUP ABO SYSTEM; GRAFT REJECTION; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; ORGAN TRANSPLANTATION; REVIEW;

ANTIBODY FORMATION; ANTIGENS, CD20; B-LYMPHOCYTES; CHILD; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; PLASMAPHERESIS; SPLENECTOMY; T-LYMPHOCYTES;

EID: 13744256095     PISSN: 13973142     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2004.00231.x     Document Type: Review

References (53)

1. TAKEMOTO SK, ZEEVI A, FENG S, et al. A national conference to assess antibody mediated rejection in solid organ transplantation. Am J Transplant 2004: 4: 1033-1041.
2. SCHELONKA RL, RAAPHORST FM, INFANTE D, KRAIG E, TEALE JM, INFANTE AJ. T cell receptor repertoire diversity and clonal expansion in human neonates. Pediatr Res 1998: 43: 396-402.
3. GARDERET L, DULPHY N, DOUAY C, et al. The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood 1998: 91: 340-346.
4. MILLER JFAP. Role of the thymus in transplantation immunity. Ann N Y Acad Sci 1962: 99: 340-354.
5. GRUNDBACHER FJ. Quantity of hemolytic anti-A and anti-B in individuals of a human population: correlations with isoagglutinins and effects of the individual's age and sex. Immun Forsch 1967: 134: 317.
6. PARKER W, LUNDBERG-SWANSON K, HOLZKNECHT ZE, et al. Isohemagglutinins and xenoreactive antibodies are members of a distinct family of natural antibodies. Hum Immunol 1996: 45: 94-104.
7. WEST LJ, POLLOCK-BARZIV SM, DIPCHAND AI, et al. ABO-incompatible heart transplantation in infants. N Engl J Med 2001: 344: 793-800.
8. KAPLON RJ, MICHLER RE, Xu H, KWIATKOWSKI PA, EDWARDS NM, PLATT JL. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation 1994: 59: 1-6.
9. JOHNSON GB, BRUNN GJ, KODAIRA Y, PLATT JL. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4. J Immunol 2002: 168: 5233-5239.
10. PRODEUS AP, GOERG S, SHEN LM, et al. A critical role for complement in maintenance of self-tolerance. Immunity 1998: 9: 721-731.
11. KESHAVARZI S, RIETZ C, SIMOES S, et al. The possibility of B-cell dependent T-cell development and function. Scand J Immunol 2003: 57: 446-452.
12. JoÃo CM, OGLE BM, GAY-RUBENSTEIN C, PLATT JL, CASCALHO M. B cell-dependent TCR diversification. J Immunol 2004: 172: 4709-4716.
13. BYSTRY RS, ALUVIHARE V, WELCH KA, KALLIKOURDIS M, BETZ AG. B cells and professional APCs recruit regulatory T cells via CCL4. Nat Immunol 2001: 2: 1126-1132.
14. LITTLE CC. The genetics of tissue transplantation in mammals. Cancer Res 1924: 8: 75-95.
15. GORER PA. The antigenic basis of tumour transplantation. J Path Bact 1938: 47: 231-252.
16. NAGATA H, ITO M, CAI J, EDGE A, PLATT JL, FOX IJ. Treatment of cirrhosis and liver failure in rats by hepato cyte xenotransplantation. Gastroenterology 2003: 124: 422-431.
17. MIYATA Y, PLATT JL. Antibody-mediated rejection. In: MUDGE GH, JARCHO JA, MITCHELL RN, eds. Heart Transplant. Philadelphia: Harcourt Health Sciences, In Press.
18. TERASAKI PI. Humoral theory of transplantation. Am J Transplant 2003: 3: 665-673.
19. MAGEE JC, COLLINS BH, HARLAND RC, et al. Immunoglobulin prevents complement mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest 1995: 96: 2404-2412.
20. BUSTOS M, SAADI S, PLATT JL. Platelet-mediated activation of endothelial cells: implications for the pathogenesis of transplant rejection. Transplantation 2001: 72: 509-515.
21. SAADI S, HOLZKNECHT RA, PATTE CP, STERN DM, PLATT JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995: 182: 1807-1814.
22. SAADI S, WRENSHALL LE, PLATT JL. Regional manifestations and control of the immune system. FASEB J 2002: 16: 849-856.
23. SAADI S, HOLZKNECHT RA, PATTE CP, PLATT JL. Endothelial cell activation by pore forming structures: pivotal role for IL-1α. Circulation 2000: 101: 1867-1873.
24. WANG CY, NAKA Y, LIAO H, et al. Cardiac graft intercellular adhesion molecule-1 (ICAM-1) and interleukin-1 expression mediate primary isograft failure and induction of ICAM-1 in organs remote from the site of transplantation. Circ Res 1998: 82: 762-772.
25. SAADI S, TAKAHASHI T, HOLZKNECHT RA, PLATT JL. Pathways to acute humoral rejection. Am J Pathol 2004: 164: 1073-1080.
26. MCCURRY KR, PARKER W, COTTERELL AH, et al. Humoral responses in pig-to-baboon cardiac transplantation: implications for the pathogenesis and treatment of acute vascular rejection and for accommodation. Hum Immunol 1997: 58: 91-105.
27. PLATT JL. C4d and the fate of organ allografts. J Am Soc Nephrol 2002: 13: 2417-2419.
28. KOCH CA, KHALPEY ZI, PLATT JL. Accommodation: preventing injury in transplantation and disease. J Immunol 2004: 172: 5143-5148.
29. CHOPEK MW, SIMMONS RL, PLATT JL. ABO-incompatible renal transplantation: initial immunopathologic evaluation. Transplant Proc 1987: 19: 4553-4557.
30. ALEXANDRE GPJ, SQUIFFLET JP, DE BRUYERE M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987: 19: 4538-4542.
31. BANNETT AD, MCALACK RF, RAJA R, BAQUERO A, MORRIS M. Experiences with known ABO-mismatched renal transplants. Transplant Proc 1987: 19: 4543-4546.
32. TERASAKI PI, MARCHIORO TL, STARZL TE. Sero-typing of human lymphocyte antigens: preliminary trials on long-term kidney homograft survivors. In: RUSSELL PS, eds. Histocompatibility Testing. Washington, D.C.: National Research Council, 1965.
33. GLEASON RE, MURRAY JE. Report from kidney transplant registry: analysis of variables in the function of human kidney transplants. Transplantation 1967: 5: 343-359.
34. WlLBRANDT R, TUNG KSK, DEODHAR SD, NAKAMOTO S, KOLFF WJ. ABO blood group incompatibility in human renal Homotransplantation. Am J Clin Pathol 1969: 51: 15-23.
35. ALEXANDRE GPJ, SQUIFFLET JP, DE BRUYERE M, et al. Splenectomy as a prerequisite for successful human ABO-incompatible renal transplantation. Transplant Proc 1985: 17: 138-143.
36. BANNETT AD, MCALACK RF, MORRIS M, CHOPEK M, PLATT JL. ABO incompatible renal transplantation: a qualitative analysis of native endothelial tissue ABO antigens after transplant. Transplant Proc 1989: 21: 783-785.
37. PLATT JL, VERCELLOTTI GM, DALMASSO AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990: 11: 450-456.
38. MOHIUDDIN MM, OGAWA H, YIN DP, SHEN J, GALILI U. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen. Transplantation 2003: 75: 258-262.
39. Yu PB, HOLZKNECHT ZE, BRUNO D, PARKER W, PLATT JL. Modulation of natural IgM binding and complement activation by natural IgG antibodies. J Immunol 1996: 157: 5163-5168.
40. YUZAWA Y, BRENTJENS JR, BRETT J, et al. Antibody-mediated redistribution and shedding of endothelial antigens in the rabbit. J Immunol 1993: 150: 5633-5646.
41. ULFVIN A, BACKER AE, CLAUSEN H, et al. Expression of glycolipid blood group antigens in single human kidneys: change in antigen expression of rejected ABO incompatible kidney grafts. Kidney Int 1993: 44: 1289-1297.
42. LIN SS, PARKER W, EVERETT ML, PLATT JL. Differential recognition by proteins of α-galactosyl residues on endothelial cell surfaces. Glycobiology 1998: 8: 433-443.
43. BACH FH, FERRAN C, HECHENLEITNER P, et al. Accommodation of vascularized xenografts: Expression of 'protective genes' by donor endothelial cells in a host Th2 cytokine environment. Nat Med 1997: 3: 196-204.
44. DORLING A, STOCKER C, TSAO T, HASKARD DO, LECHLER RI. In vitro accommodation of immortalized porcine endothelial cells: resistance to complement mediated lysis and down-regulation of VCAM expression induced by low concentrations of polyclonal human IgG antipig antibodies. Transplantation 1996: 62: 1127-1136.
45. DALMASSO AP, BENSON BA, JOHNSON JS, LANCTO C, ABRAHAMSEN MS. Resistance against the membrane attack complex of complement induced in porcine endothelial cells with a Gal alpha(1-3)Gal binding lectin: up-regulation of CD59 expression. J Immunol 2000: 164: 3764-3773.
46. PARK W, GRANDE JP, D. N, et al. Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury. Am J Transplant 2003: 3: 952-960.
47. ARANDA JM Jr, SCORNIK JC, NORMANN SJ, et al. Anti-CD20 monoclonal antibody (rituximab) therapy for acute cardiac humoral rejection: a case report. Transplantation 2002: 73: 907-910.
48. GARRETT HE Jr, GROSHART K, DUVALL-SEAMAN D, COMBS D, SUGGS R. Treatment of humoral rejection with rituximab. Ann Thorac Surg 2002: 74: 1240-1242.
49. TEDDER TF, ZHOU LJ, ENGEL P. The CD19/CD21 signal transduction complex of B lymphocytes. Immunol Today 1994: 15: 437-442.
50. UCHIDA J, LEE Y, HASEGAWA M, et al expression and function. Int Immunol 2004: 16: 119-129.
51. TYAN DB, LI VA, CZER L, TRENTO A, JORDAN SC. Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ. Transplantation 1994: 57: 553-562.
52. JORDAN SC, QUARTEL AW, CZER LSC, et al. Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action. Transplantation 1998: 66: 800-805.
53. BANOWSKY LH, CORTESE J, LUTTON JJ, SAUNDERS PH. Plasmapheresis-adjunctive treatment for steroid-resistant rejection in renal transplantation. J Urol 1984: 131: 14-16.